Skip to main content
PACSPACS Group, Inc.Sell5.6·$36.20-0.23%
Open full analysis

PACS Group, Inc. (PACS) Stock Analysis

SellVALUE-TRAP 1/5Moderate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Multiple concerning factors at $36.20: Leverage penalty (D/E 3.4): -1.5; Concentration risk — Geographic: California.

PACS Group is one of the largest skilled nursing facility operators in the US, operating 321 post-acute care facilities across 17 states serving 31,700+ patients daily. Revenue of $5.3B in 2025 comes primarily from Medicare (33.7%) and Medicaid (40.5%) reimbursements; the... Read more

$36.20+18.2% A.UpsideScore 5.6/10#11 of 27 Medical Care Facilities
QualityF-score6 / 9FCF yield5.28%
Stop $33.67Target $42.78(analyst − 13%)A.R:R 1.9:1
Analyst target$49.17+35.8%6 analysts
$42.78our TP
$36.20price
$49.17mean
$52

Sell if holding. Multiple concerning factors at $36.20: Leverage penalty (D/E 3.4): -1.5; Concentration risk — Geographic: California. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.6/10, moderate confidence.

Passes 7/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 56d clear, semi cycle peak clear, materials cycle peak clear). Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-15
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Aug 10, 202656d to earnings· next earnings call

Thesis

Rewards
Strong growth profile
Risks
Concentration risk — Geographic: California
Leverage penalty (D/E 3.4): -1.5
Consecutive earnings misses (2)

Key Metrics

P/E (TTM)23.4
P/E (Fwd)14.5
Mkt Cap$5.7B
EV/EBITDA20.4
Profit Mgn4.5%
ROE27.1%
Rev Growth11.2%
Beta0.00
DividendNone
Rating analysts12

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C1.14bearish
IV83%elevated
Max Pain$3-93.1% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMCustomerMedicare34%
    10-K Item 1: 'Medicare and Medicaid, which represent our largest sources of revenue and accounted for 33.7% and 40.5% of our routine revenue for the year ended December 31, 2025, respectively.'
  • MEDIUMCustomerMedicaid41%
    10-K Item 1: 'Medicare and Medicaid, which represent our largest sources of revenue and accounted for 33.7% and 40.5% of our routine revenue for the year ended December 31, 2025, respectively.'
  • HIGHGeographicCalifornia
    10-K Item 1: 'The majority of these leased facilities are in California'

Material Events(8-K, last 90d)

  • 2026-04-27Item 5.02MEDIUM
    Carey Hendrickson appointed CFO effective April 27, 2026 (successor named, previously CFO at U.S. Physical Therapy). Mark Hancock ceases as Interim CFO but remains Executive Vice Chairman; plans to retire June 30, 2026.
    SEC filing →
  • 2026-03-05Item 5.02LOW
    Patrick H. Conway, MD, MSc appointed to Board as Class III director effective March 4, 2026. No family relationships or related-party transactions disclosed. No reason cited.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesMomentum 4.7<5.5 (soft — BUY_NOW allowed but watch)Executive change: officer departure/appointmentMomentum 4.7>=4.5A.R:R 1.9 ≥ 1.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 56d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
39 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $34.07Resistance $39.62

Price Targets

$34
$43
A.Upside+18.2%
A.R:R1.9:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Analyst Consensus

Analysts12
Consensus4.3/5
Avg Target$49

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-08-10 (56d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is PACS stock a buy right now?

Sell if holding. Multiple concerning factors at $36.20: Leverage penalty (D/E 3.4): -1.5; Concentration risk — Geographic: California. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $33.67. Score 5.6/10, moderate confidence.

What is the PACS stock price target?

Take-profit target: $42.78 (+18.2% upside). Prior stop was $33.67. Stop-loss: $33.67.

What are the risks of investing in PACS?

Concentration risk — Geographic: California; Leverage penalty (D/E 3.4): -1.5; Consecutive earnings misses (2).

Is PACS overvalued or undervalued?

PACS Group, Inc. trades at a P/E of 23.4 (forward 14.5). TrendMatrix value score: 6.5/10. Verdict: Sell.

What do analysts say about PACS?

12 analysts cover PACS with a consensus score of 4.3/5. Average price target: $49.

What does PACS Group, Inc. do?PACS Group is one of the largest skilled nursing facility operators in the US, operating 321 post-acute care facilities...

PACS Group is one of the largest skilled nursing facility operators in the US, operating 321 post-acute care facilities across 17 states serving 31,700+ patients daily. Revenue of $5.3B in 2025 comes primarily from Medicare (33.7%) and Medicaid (40.5%) reimbursements; the majority of leased facilities are in California.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · THC (Tenet Healthcare Corporation) · UHS (Universal Health Services, Inc.) · ASTH (Astrana Health Inc.) · CON (Concentra Group Holdings Parent)
Home Stocks PACS

Latest news

Latest News

Marketscreener.com40d ago
The Globe and Mail48d agoRestructuring
Yahoo Finance49d ago
Msn.com35d ago
富途牛牛41d agoEarnings
Moomoo41d agoEarnings
Bloomingbit39d ago
MSN49d ago
Investing.com Canada49d agoRestructuring
Business Wire49d agoRestructuring
Yahoo Finance49d agoAnalyst
TipRanks35d ago
Marketscreener.com35d agoEarnings
TradingView35d agoEarnings
Marketscreener.com35d ago
Investing.com UK35d agoEarnings
Yahoo Finance35d ago
TipRanks45d agoMerger Acquisition
Investing.com45d agoMerger Acquisition
Investing.com Canada45d agoMerger Acquisition
Loading more...